ALT 0 3 0 3 B-clinical_variable
≤ 4 5 4 5 O
3 6 7 6 7 B-upper_bound
times 8 13 8 13 I-upper_bound
the 14 17 14 17 I-upper_bound
institutional 18 31 18 31 I-upper_bound
upper 32 37 32 37 I-upper_bound
limit 38 43 38 43 I-upper_bound
of 44 46 44 46 I-upper_bound
normal 47 53 47 53 I-upper_bound

AST 0 3 54 57 B-clinical_variable
≤ 4 5 58 59 O
3 6 7 60 61 B-upper_bound
times 8 13 62 67 I-upper_bound
the 14 17 68 71 I-upper_bound
institutional 18 31 72 85 I-upper_bound
upper 32 37 86 91 I-upper_bound
limit 38 43 92 97 I-upper_bound
of 44 46 98 100 I-upper_bound
normal 47 53 101 107 I-upper_bound

Absolute 0 8 108 116 B-clinical_variable
neutrophil 9 19 117 127 I-clinical_variable
count 20 25 128 133 I-clinical_variable
( 26 27 134 135 I-clinical_variable
ANC 27 30 135 138 I-clinical_variable
) 30 31 138 139 I-clinical_variable
≥ 32 33 140 141 O
1500 34 38 142 146 B-lower_bound
cells 39 44 147 152 I-lower_bound
per 45 48 153 156 I-lower_bound
mm3 49 52 157 160 I-lower_bound

Age 0 3 161 164 B-age
≥ 4 5 165 166 O
18 6 8 167 169 B-lower_bound
years 9 14 170 175 I-lower_bound

Breastfeeding 0 13 176 189 O
women 14 19 190 195 B-gender

Creatinine 0 10 196 206 B-clinical_variable
≤ 11 12 207 208 O
2.0 13 16 209 212 B-upper_bound
mg 17 19 213 215 I-upper_bound

Diagnosis 0 9 216 225 O
must 10 14 226 230 O
be 15 17 231 233 O
made 18 22 234 238 O
by 23 25 239 241 O
surgical 26 34 242 250 O
biopsy 35 41 251 257 B-treatment
or 42 44 258 260 O
excision 45 53 261 269 O

ECOG 0 4 270 274 B-clinical_variable
performance 5 16 275 286 I-clinical_variable
status 17 23 287 293 I-clinical_variable
0 24 25 294 295 B-lower_bound
- 25 26 295 296 O
2 26 27 296 297 B-upper_bound
. 27 28 297 298 O
( 29 30 299 300 O
KPS 30 33 300 303 B-clinical_variable
> 34 35 304 305 O
50 36 38 306 308 B-lower_bound
) 38 39 308 309 O

G6PD 0 4 310 314 B-chronic_disease
( 5 6 315 316 I-chronic_disease
glucose-6 6 15 316 325 I-chronic_disease
- 15 16 325 326 I-chronic_disease
phosphate 16 25 326 335 I-chronic_disease
dehydrogenase 26 39 336 349 I-chronic_disease
) 39 40 349 350 I-chronic_disease
deficiency 41 51 351 361 I-chronic_disease

Hemoglobin 0 10 362 372 B-clinical_variable
≥ 11 12 373 374 O
8 13 14 375 376 B-lower_bound
g 15 16 377 378 I-lower_bound
/ 16 17 378 379 I-lower_bound
dL 17 19 379 381 I-lower_bound

High 0 4 382 386 O
- 4 5 386 387 O
dose 5 9 387 391 O
ascorbate 10 19 392 401 B-treatment
acid 20 24 402 406 I-treatment
is 25 27 407 409 O
a 28 29 410 411 O
known 30 35 412 417 O
CYP450 36 42 418 424 B-treatment
3A4 43 46 425 428 I-treatment
inducer 47 54 429 436 O
, 54 55 436 437 O
which 56 61 438 443 O
results 62 69 444 451 O
in 70 72 452 454 O
lower 73 78 455 460 B-clinical_variable
serum 79 84 461 466 I-clinical_variable
levels 85 91 467 473 I-clinical_variable
of 92 94 474 476 O
antiretroviral 95 109 477 491 B-treatment
drugs 110 115 492 497 I-treatment

History 0 7 498 505 O
of 8 10 506 508 O
allergic 11 19 509 517 O
reactions 20 29 518 527 O
attributed 30 40 528 538 O
to 41 43 539 541 O
compounds 44 53 542 551 O
of 54 56 552 554 O
similar 57 64 555 562 O
chemical 65 73 563 571 O
or 74 76 572 574 O
biologic 77 85 575 583 O
composition 86 97 584 595 O
to 98 100 596 598 O
temozolomide 101 113 599 611 B-allergy_name

Known 0 5 612 617 O
HIV 6 9 618 621 B-chronic_disease
- 9 10 621 622 O
positive 10 18 622 630 O
individuals 19 30 631 642 O

Known 0 5 643 648 O
active 6 12 649 655 O
concurrent 13 23 656 666 O
malignancy 24 34 667 677 B-cancer
, 34 35 677 678 O
as 36 38 679 681 O
determined 39 49 682 692 O
by 50 52 693 695 O
treating 53 61 696 704 O
physicians 62 72 705 715 O

Not 0 3 716 719 B-pregnancy
pregnant 4 12 720 728 I-pregnancy

Patients 0 8 729 737 O
actively 9 17 738 746 O
receiving 18 27 747 756 O
insulin 28 35 757 764 B-treatment
or 36 38 765 767 O
using 39 44 768 773 O
a 45 46 774 775 O
finger 47 53 776 782 B-treatment
- 53 54 782 783 I-treatment
stick 54 59 783 788 I-treatment
glucometer 60 70 789 799 I-treatment
daily 71 76 800 805 O
for 77 80 806 809 O
blood 81 86 810 815 O
glucose 87 94 816 823 O
measurements 95 107 824 836 O

Patients 0 8 837 845 O
must 9 13 846 850 O
have 14 18 851 855 O
newly 19 24 856 861 O
diagnosed 25 34 862 871 O
( 35 36 872 873 O
i.e. 36 40 873 877 O
, 40 41 877 878 O
within 42 48 879 885 O
5 49 50 886 887 B-upper_bound
weeks 51 56 888 893 I-upper_bound
) 56 57 893 894 O
, 57 58 894 895 O
histologically 59 73 896 910 O
or 74 76 911 913 O
cytologically 77 90 914 927 O
confirmed 91 100 928 937 O
glioblastoma 101 113 938 950 B-cancer
multiforme 114 124 951 961 I-cancer

Patients 0 8 962 970 O
receiving 9 18 971 980 O
any 19 22 981 984 O
other 23 28 985 990 O
investigational 29 44 991 1006 B-treatment
agents 45 51 1007 1013 I-treatment
( 52 53 1014 1015 O
imaging 53 60 1015 1022 B-treatment
agents 61 67 1023 1029 I-treatment
are 68 71 1030 1033 O
acceptable 72 82 1034 1044 O
) 82 83 1044 1045 O

Patients 0 8 1046 1054 O
who 9 12 1055 1058 O
are 13 16 1059 1062 O
on 17 19 1063 1065 O
the 20 23 1066 1069 O
following 24 33 1070 1079 O
drugs 34 39 1080 1085 O
and 40 43 1086 1089 O
can 44 47 1090 1093 O
not 47 50 1093 1096 O
have 51 55 1097 1101 O
a 56 57 1102 1103 O
drug 58 62 1104 1108 O
substitution 63 75 1109 1121 O
: 75 76 1121 1122 O
warfarin 77 85 1123 1131 B-treatment
, 85 86 1131 1132 O
flecainide 87 97 1133 1143 B-treatment
, 97 98 1143 1144 O
methadone 99 108 1145 1154 B-treatment
, 108 109 1154 1155 O
amphetamines 110 122 1156 1168 B-treatment
, 122 123 1168 1169 O
quinidine 124 133 1170 1179 B-treatment
, 133 134 1179 1180 O
and 135 138 1181 1184 O
chlorpropamide 139 153 1185 1199 B-treatment

Patients 0 8 1200 1208 O
who 9 12 1209 1212 O
have 13 17 1213 1217 O
received 18 26 1218 1226 O
prior 27 32 1227 1232 B-treatment
chemotherapy 33 45 1233 1245 I-treatment
( 46 47 1246 1247 O
including 47 56 1247 1256 O
Gliadel 57 64 1257 1264 B-treatment
wafers 65 71 1265 1271 I-treatment
) 71 72 1271 1272 O
for 73 76 1273 1276 O
the 77 80 1277 1280 O
current 81 88 1281 1288 O
glioma 89 95 1289 1295 B-cancer

Platelets 0 9 1296 1305 B-clinical_variable
≥ 10 11 1306 1307 O
100,000 12 19 1308 1315 B-lower_bound
per 20 23 1316 1319 I-lower_bound
mm3 24 27 1320 1323 I-lower_bound

Pregnant 0 8 1324 1332 B-pregnancy
women 9 14 1333 1338 B-gender

Prior 0 5 1339 1344 B-treatment
radiation 6 15 1345 1354 I-treatment
therapy 16 23 1355 1362 I-treatment
to 24 26 1363 1365 O
the 27 30 1366 1369 O
head 31 35 1370 1374 O
or 36 38 1375 1377 O
neck 39 43 1378 1382 O
resulting 44 53 1383 1392 O
in 54 56 1393 1395 O
overlap 57 64 1396 1403 O
of 65 67 1404 1406 O
RT 68 70 1407 1409 O
fields 71 77 1410 1416 O

Recurrent 0 9 1417 1426 O
high 10 14 1427 1431 B-cancer
grade 15 20 1432 1437 I-cancer
glioma 21 27 1438 1444 I-cancer

Significant 0 11 1445 1456 O
co 12 14 1457 1459 O
- 14 15 1459 1460 O
morbid 15 21 1460 1466 O
central 22 29 1467 1474 B-chronic_disease
nervous 30 37 1475 1482 I-chronic_disease
system 38 44 1483 1489 I-chronic_disease
disease 45 52 1490 1497 I-chronic_disease
, 52 53 1497 1498 O
including 54 63 1499 1508 O
but 64 67 1509 1512 O
not 68 71 1513 1516 O
limited 72 79 1517 1524 O
to 80 82 1525 1527 O
, 82 83 1527 1528 O
multiple 84 92 1529 1537 B-chronic_disease
sclerosis 93 102 1538 1547 I-chronic_disease

Therapy 0 7 1548 1555 B-treatment
must 8 12 1556 1560 O
begin 13 18 1561 1566 O
≤ 19 20 1567 1568 O
5 21 22 1569 1570 B-upper_bound
weeks 23 28 1571 1576 I-upper_bound
after 29 34 1577 1582 I-upper_bound
surgery 35 42 1583 1590 B-treatment
or 43 45 1591 1593 O
biopsy 46 52 1594 1600 B-treatment

Tolerate 0 8 1601 1609 O
one 9 12 1610 1613 O
test 13 17 1614 1618 O
dose 18 22 1619 1623 O
( 23 24 1624 1625 O
15 24 26 1625 1627 B-upper_bound
g 26 27 1627 1628 I-upper_bound
) 27 28 1628 1629 O
of 29 31 1630 1632 O
ascorbate 32 41 1633 1642 B-treatment

Total 0 5 1643 1648 B-clinical_variable
bilirubin 6 15 1649 1658 I-clinical_variable
≤ 16 17 1659 1660 O
1.5 18 21 1661 1664 B-upper_bound
mg 22 24 1665 1667 I-upper_bound
/ 24 25 1667 1668 I-upper_bound
dL 25 27 1668 1670 I-upper_bound

Uncontrolled 0 12 1671 1683 O
intercurrent 13 25 1684 1696 B-chronic_disease
illness 26 33 1697 1704 I-chronic_disease
including 34 43 1705 1714 O
, 43 44 1714 1715 O
but 45 48 1716 1719 O
not 49 52 1720 1723 O
limited 53 60 1724 1731 O
to 61 63 1732 1734 O
, 63 64 1734 1735 O
ongoing 65 72 1736 1743 O
or 73 75 1744 1746 O
active 76 82 1747 1753 B-chronic_disease
infection 83 92 1754 1763 I-chronic_disease
that 93 97 1764 1768 O
would 98 103 1769 1774 O
result 104 110 1775 1781 O
in 111 113 1782 1784 O
a 114 115 1785 1786 O
hospital 116 124 1787 1795 O
stay 125 129 1796 1800 O
or 130 132 1801 1803 O
delay 133 138 1804 1809 O
of 139 141 1810 1812 O
treatment 142 151 1813 1822 B-treatment
, 151 152 1822 1823 O
symptomatic 153 164 1824 1835 O
congestive 165 175 1836 1846 B-chronic_disease
heart 176 181 1847 1852 I-chronic_disease
failure 182 189 1853 1860 I-chronic_disease
, 189 190 1860 1861 O
unstable 191 199 1862 1870 B-chronic_disease
angina 200 206 1871 1877 I-chronic_disease
pectoris 207 215 1878 1886 I-chronic_disease
, 215 216 1886 1887 O
cardiac 217 224 1888 1895 B-chronic_disease
arrhythmia 225 235 1896 1906 I-chronic_disease
, 235 236 1906 1907 O
or 237 239 1908 1910 O
psychiatric 240 251 1911 1922 B-chronic_disease
illness 252 259 1923 1930 I-chronic_disease
/ 259 260 1930 1931 O
social 260 266 1931 1937 O
situations 267 277 1938 1948 O
that 278 282 1949 1953 O
would 283 288 1954 1959 O
limit 289 294 1960 1965 O
compliance 295 305 1966 1976 O
with 306 310 1977 1981 O
study 311 316 1982 1987 O
requirements 317 329 1988 2000 O
or 330 332 2001 2003 O
impact 333 339 2004 2010 O
patient 340 347 2011 2018 O
safety 348 354 2019 2025 O

